JPMORGAN CHASE & CO - 31 Dec 2025 SCHEDULE 13G/A Report for RADIOPHARM THERANOSTICS LIMITED Ordinary Shares, as represented by American Depositary Shares (RADX)

Filing Manager
JPMORGAN CHASE & CO
Reporting Manager
JPMORGAN CHASE & CO.
Security
RADIOPHARM THERANOSTICS LIMITED Ordinary Shares, as represented by American Depositary Shares
Symbol
RADX
Shares outstanding
3,641,998,775 shares
Disclosed Ownership
145,679,951 shares
Ownership
4%
Form type
SCHEDULE 13G/A
Filing time
16 Jan 2026, 11:31:34 UTC
Date of event
31 Dec 2025
Previous filing
16 Jul 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"JPMORGAN CHASE & CO disclosed 4% ownership in RADIOPHARM THERANOSTICS LIMITED Ordinary Shares, as represented by American Depositary Shares (RADX) on 31 Dec 2025."

Quick Takeaways

  • JPMORGAN CHASE & CO filed SCHEDULE 13G/A for RADIOPHARM THERANOSTICS LIMITED Ordinary Shares, as represented by American Depositary Shares (RADX).
  • Disclosed ownership: 4%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 16 Jul 2025.
  • Current filing was accepted on 16 Jan 2026, 11:31.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JPMORGAN CHASE & CO. 4% 145,679,951 145,679,951 0 Rachel Tsvaygoft Vice President

Sponsored